• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痉挛性发声障碍的诊断延误:呼吁对临床医生进行教育。

Diagnostic Delays in Spasmodic Dysphonia: A Call for Clinician Education.

作者信息

Creighton Francis X, Hapner Edie, Klein Adam, Rosen Ami, Jinnah Hyder A, Johns Michael M

机构信息

Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts.

Department of Otolaryngology-Head and Neck Surgery, Emory Voice Center, Emory University School of Medicine, Atlanta, Georgia.

出版信息

J Voice. 2015 Sep;29(5):592-4. doi: 10.1016/j.jvoice.2013.10.022. Epub 2015 Apr 11.

DOI:10.1016/j.jvoice.2013.10.022
PMID:25873547
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4868351/
Abstract

PURPOSE

Spasmodic dysphonia (SD) is a rare but often debilitating disease. Due to lack of awareness among practitioners and lack of well-defined diagnostic criteria, it can be difficult for patients with SD to receive a diagnosis and subsequent treatment. There is currently no literature documenting the efficacy of the medical community in recognizing and diagnosing this disorder. We aimed to quantify the patients' experiences with obtaining a diagnosis of SD.

METHODS

One hundred seven consecutive patients with SD completed questionnaires about their experiences with SD. Patients were recruited either during outpatient laryngology visits or during participation in a National Institutes of Health funded study investigating SD.

RESULTS

It took patients an average of 4.43 years (53.21 months) to be diagnosed with SD after first going to a physician with vocal symptoms. Patients had to see an average of 3.95 physicians to receive a diagnosis of SD. Patients (31.4%) had been prescribed medications other than botulinum toxin to treat their symptoms. Patients (30%) attempted alternative therapies for treatment of SD, such as chiropractor or dietary modification.

CONCLUSIONS

Despite advances in diagnostic modalities in medicine, the diagnosis of SD still remains elusive. Objective criteria for the diagnosis of SD and increased clinician education are warranted to address this diagnostic delay.

摘要

目的

痉挛性发声障碍(SD)是一种罕见但常使人衰弱的疾病。由于从业者认识不足且缺乏明确的诊断标准,SD患者可能难以获得诊断及后续治疗。目前尚无文献记录医学界在识别和诊断这种疾病方面的成效。我们旨在量化患者获得SD诊断的经历。

方法

107例连续性SD患者完成了关于其SD经历的问卷调查。患者通过门诊喉科就诊或参与美国国立卫生研究院资助的SD研究招募。

结果

患者首次因嗓音症状就医后,平均需要4.43年(53.21个月)才能被诊断为SD。患者平均需要看3.95名医生才能获得SD诊断。31.4%的患者曾被开具除肉毒杆菌毒素以外的药物来治疗症状。30%的患者尝试过替代疗法来治疗SD,如脊椎按摩或饮食调整。

结论

尽管医学诊断方式有所进步,但SD的诊断仍然难以捉摸。有必要制定SD的客观诊断标准并加强临床医生培训,以解决这一诊断延迟问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c820/4868351/1080a58b526c/nihms785696f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c820/4868351/7259921ec2c6/nihms785696f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c820/4868351/1080a58b526c/nihms785696f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c820/4868351/7259921ec2c6/nihms785696f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c820/4868351/1080a58b526c/nihms785696f2.jpg

相似文献

1
Diagnostic Delays in Spasmodic Dysphonia: A Call for Clinician Education.痉挛性发声障碍的诊断延误:呼吁对临床医生进行教育。
J Voice. 2015 Sep;29(5):592-4. doi: 10.1016/j.jvoice.2013.10.022. Epub 2015 Apr 11.
2
Clinical practice guideline: hoarseness (dysphonia).临床实践指南:声音嘶哑(发音困难)。
Otolaryngol Head Neck Surg. 2009 Sep;141(3 Suppl 2):S1-S31. doi: 10.1016/j.otohns.2009.06.744.
3
Voice disorders in the workplace: productivity in spasmodic dysphonia and the impact of botulinum toxin.职场中的嗓音障碍:痉挛性发音障碍的生产力和肉毒毒素的影响。
Laryngoscope. 2013 Nov;123 Suppl 6:S1-14. doi: 10.1002/lary.24292.
4
The Mayo Clinic Arizona Spasmodic Dysphonia Experience: A Demographic Analysis of 718 Patients.梅奥诊所亚利桑那州痉挛性发声障碍诊疗经验:718例患者的人口统计学分析
Ann Otol Rhinol Laryngol. 2015 Nov;124(11):859-63. doi: 10.1177/0003489415588557. Epub 2015 May 29.
5
Spasmodic dysphonia: let's look at that again.痉挛性发声障碍:让我们再看看那个。
J Voice. 2014 Nov;28(6):694-9. doi: 10.1016/j.jvoice.2014.03.007. Epub 2014 Jun 24.
6
Considerations for initial dosing of botulinum toxin in treatment of adductor spasmodic dysphonia.考虑在治疗内收肌痉挛性发音障碍时初次使用肉毒毒素的剂量。
Otolaryngol Head Neck Surg. 2013 Jun;148(6):1003-6. doi: 10.1177/0194599813484685. Epub 2013 Mar 27.
7
A comparison of the VHI, VHI-10, and V-RQOL for measuring the effect of botox therapy in adductor spasmodic dysphonia.比较 VHI、VHI-10 和 V-RQOL 在评估肉毒毒素治疗内收肌痉挛性发音障碍中的疗效。
J Voice. 2012 May;26(3):378-80. doi: 10.1016/j.jvoice.2010.07.011. Epub 2010 Oct 16.
8
Dysphonia in performers: toward a clinical definition of laryngology of the performing voice.表演者的发声障碍:迈向表演嗓音喉科学的临床定义
J Voice. 2014 May;28(3):349-55. doi: 10.1016/j.jvoice.2013.10.004. Epub 2013 Dec 8.
9
The Impact of Socioeconomic Status on Voice Outcomes in Patients With Spasmodic Dysphonia Treated With Botulinum Toxin Injections.社会经济地位对肉毒杆菌毒素注射治疗痉挛性发声障碍患者嗓音结局的影响
Ann Otol Rhinol Laryngol. 2019 Apr;128(4):316-322. doi: 10.1177/0003489418823013. Epub 2019 Jan 7.
10
Socioeconomic Variables of Patients with Spasmodic Dysphonia: A Preliminary Study.痉挛性发声障碍患者的社会经济变量:一项初步研究。
J Voice. 2018 Jul;32(4):479-483. doi: 10.1016/j.jvoice.2017.07.015. Epub 2017 Sep 18.

引用本文的文献

1
Comparing the Effects of Sensory Tricks on Voice Symptoms in Patients With Laryngeal Dystonia and Essential Vocal Tremor.比较感觉技巧对喉肌张力障碍和特发性声带震颤患者声音症状的影响。
J Speech Lang Hear Res. 2025 Apr 8;68(4):1654-1675. doi: 10.1044/2024_JSLHR-24-00476. Epub 2025 Feb 27.
2
Supraglottic Laryngeal Maneuvers in Adductor Laryngeal Dystonia During Connected Speech.连串言语期间内收性喉肌张力障碍中的声门上喉部手法
J Voice. 2024 Aug 30. doi: 10.1016/j.jvoice.2024.08.009.
3
Demographic and clinical characteristics of our patients diagnosed with laryngeal dystonia.

本文引用的文献

1
Consideration of genetic contributions to the risk for spasmodic dysphonia.考虑遗传因素对痉挛性发声障碍风险的影响。
Otolaryngol Head Neck Surg. 2011 Sep;145(3):369-70. doi: 10.1177/0194599811411656. Epub 2011 Jun 2.
2
Research priorities in spasmodic dysphonia.痉挛性发声障碍的研究重点
Otolaryngol Head Neck Surg. 2008 Oct;139(4):495-505. doi: 10.1016/j.otohns.2008.05.624.
3
Epidemiology, clinical presentation, and diagnosis of cervical dystonia.颈部肌张力障碍的流行病学、临床表现及诊断
我们诊断为喉肌痉挛患者的人口统计学和临床特征。
Eur Arch Otorhinolaryngol. 2024 Aug;281(8):4265-4271. doi: 10.1007/s00405-024-08688-9. Epub 2024 May 7.
4
Clinical Implications of Dystonia as a Neural Network Disorder.作为一种神经网络障碍的肌张力障碍的临床意义。
Adv Neurobiol. 2023;31:223-240. doi: 10.1007/978-3-031-26220-3_13. Epub 2023 Jun 21.
5
Automated Creak Differentiates Adductor Laryngeal Dystonia and Muscle Tension Dysphonia.自动咔哒声可区分内收性喉痉挛和肌肉紧张性发音障碍。
Laryngoscope. 2023 Oct;133(10):2687-2694. doi: 10.1002/lary.30588. Epub 2023 Jan 30.
6
Symptom Expression Across Voiced Speech Sounds in Adductor Laryngeal Dystonia.内收型喉肌张力障碍中浊语音的症状表现
J Voice. 2025 Mar;39(2):567.e23-567.e30. doi: 10.1016/j.jvoice.2022.10.002. Epub 2022 Nov 21.
7
Spectral Aggregate of the High-Passed Fundamental Frequency and Its Relationship to the Primary Acoustic Features of Adductor Laryngeal Dystonia.基频带通后的频谱总和及其与收束性喉肌张力障碍主要声学特征的关系。
J Speech Lang Hear Res. 2022 Nov 17;65(11):4085-4095. doi: 10.1044/2022_JSLHR-22-00157. Epub 2022 Oct 5.
8
The Patho-Neurophysiological Basis and Treatment of Focal Laryngeal Dystonia: A Narrative Review and Two Case Reports Applying TMS over the Laryngeal Motor Cortex.局灶性喉肌张力障碍的病理神经生理学基础与治疗:一项叙述性综述及两例在喉运动皮层应用经颅磁刺激的病例报告
J Clin Med. 2022 Jun 15;11(12):3453. doi: 10.3390/jcm11123453.
9
Botulinum Toxin Therapy: A Series of Clinical Studies on Patients with Spasmodic Dysphonia in Japan.肉毒杆菌毒素治疗:日本痉挛性发声障碍患者的一系列临床研究。
Toxins (Basel). 2021 Nov 25;13(12):840. doi: 10.3390/toxins13120840.
10
Post-treatment clinical course following botulinum toxin injection therapy for adductor spasmodic dysphonia: Analysis of data from a placebo-controlled, randomized, double-blinded clinical trial in Japan.肉毒杆菌毒素注射疗法治疗内收型痉挛性发声障碍后的治疗后临床过程:来自日本一项安慰剂对照、随机、双盲临床试验的数据分析。
Laryngoscope Investig Otolaryngol. 2021 Sep 28;6(5):1088-1095. doi: 10.1002/lio2.669. eCollection 2021 Oct.
Neurol Clin. 2008 May;26 Suppl 1:23-42. doi: 10.1016/s0733-8619(08)80003-5.
4
Prevalence of cervical dystonia and spasmodic torticollis in the United States general population.美国普通人群中颈部肌张力障碍和痉挛性斜颈的患病率。
Parkinsonism Relat Disord. 2007 Oct;13(7):411-6. doi: 10.1016/j.parkreldis.2007.02.005. Epub 2007 Apr 17.
5
Risk factors and demographics in patients with spasmodic dysphonia.痉挛性发音障碍患者的风险因素及人口统计学特征
Laryngoscope. 2002 Feb;112(2):220-3. doi: 10.1097/00005537-200202000-00004.